305 related articles for article (PubMed ID: 20971821)
1. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
Molica S; Mauro FR; Giannarelli D; Lauria F; Cortelezzi A; Brugiatelli M; Liso V; Cuneo A; Foà R
Haematologica; 2011 Feb; 96(2):277-83. PubMed ID: 20971821
[TBL] [Abstract][Full Text] [Related]
2. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
[TBL] [Abstract][Full Text] [Related]
3. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
[TBL] [Abstract][Full Text] [Related]
4. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.
Molica S; Mauro FR; Callea V; Giannarelli D; Lauria F; Rotoli B; Cortelezzi A; Liso V; Foà R
Haematologica; 2010 Mar; 95(3):464-9. PubMed ID: 19903673
[TBL] [Abstract][Full Text] [Related]
5. A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
Molica S; Mauro FR; Callea V; Gentile M; Giannarelli D; Lopez M; Lauria F; Rotoli B; Montanaro M; Cortelezzi A; Liso V; Mandelli F; Foa R;
Leuk Lymphoma; 2005 Apr; 46(4):553-60. PubMed ID: 16032778
[TBL] [Abstract][Full Text] [Related]
6. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
Angelillo P; Capasso A; Ghia P; Scarfò L
Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
[TBL] [Abstract][Full Text] [Related]
9. Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.
Molica S; Giannarelli D; Mirabelli R; Levato L; Gentile M; Lentini M; Morabito F
Expert Rev Hematol; 2014 Oct; 7(5):691-5. PubMed ID: 25174547
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
[TBL] [Abstract][Full Text] [Related]
11. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
Strati P; Shanafelt TD
Blood; 2015 Jul; 126(4):454-62. PubMed ID: 26065657
[TBL] [Abstract][Full Text] [Related]
13. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.
Villegas Gracia R; Franco Alzate C; Rendón Henao J; Torres Hernández JD; Jaramillo Arbelaez PE
Colomb Med (Cali); 2016 Jun; 47(2):81-6. PubMed ID: 27546929
[TBL] [Abstract][Full Text] [Related]
14. Combination of cellular population data and CytoDiff analyses for the diagnosis of lymphocytosis.
Jean A; Boutet C; Lenormand B; Callat MP; Buchonnet G; Leclerc C; Vasse M
Clin Chem Lab Med; 2011 Nov; 49(11):1861-8. PubMed ID: 21875393
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].
Schindhelm RK; van Marwijk Kooy MR; Coenen JL; Huijgens PC; Kuiper-Kramer PA
Ned Tijdschr Geneeskd; 2010; 154():A1520. PubMed ID: 20482911
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
Ryder CB; Oduro KA; Moore EM
Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
[TBL] [Abstract][Full Text] [Related]
17. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
[TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
